CONMED (CNMD) Stock Looks Like A Bargain Despite Its 65% Fall
CNMD Q3 deep dive: stable revenue, margin improvement, and focus on core growth platforms
CONMED Corporation to Participate in the Jefferies Global Healthcare Conference
CONMED Corporation 2026 Q3 - Results - Earnings Call Presentation
The top 5 analyst questions from CONMED’s Q3 earnings call
CONMED (CNMD) Shares Dropped, So What Is Going On?
JP Morgan Maintains Neutral on Conmed, Raises Price Target to $50
CONMED Corporation Q3 2026 Earnings Call Summary
Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $49
CONMED Q3 Earnings Call Highlights
CONMED (CNMD) Q3 2026 Earnings Call Transcript
CONMED Corporation (CNMD) Q3 2026 Earnings Call Transcript
CONMED Corporation Reports Third Quarter 2026 Net Sales of $335.6 million and Updates Full Year 2026 Guidance
CONMED (NYSE:CNMD) Shares Jump 18.9% as Organic Growth and EPS Offset Revenue Miss
Here's What Key Metrics Tell Us About Conmed (CNMD) Q3 Earnings
CONMED (NYSE:CNMD) posts Q3 2026 sales in line with estimates
Conmed: Q3 Earnings Snapshot
CONMED Corporation Reports Third Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
Conmed Q3 2026 Earnings Call Transcript
Conmed Raises FY2026 Adj EPS Guidance from $4.48-$4.60 to $4.54-$4.61 vs $4.54 Est; Narrows FY2026 Sales Guidance from $1.358B-$1.373B to $1.360B-$1.366B vs $1.366B Est
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.